3Konturek SJ. Konlurek PC, Konturek JW, et al. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.J PhysiolPharmacol, 2006,57 (Suppl 3): 29-50.
4Atherton JC. The pathugenesis of Helicobacter pylori induced gastro duodenal diseases. Annu Rev Pathol,2006,1:63-96.
5Hamajima N. Persistent Helieobacter pylori infection and genetic polymorphisms of the host. Nagoya J Med Sci, 2003, 66: 103-117.
6Dincer D, Duman A, Dikici H, et al. NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis? Int J Clin Pract,2006,60 : 546-548.
7Zapata Colindres JC, Zepeda Gomez S, Montano Loza A, et al. The association of Helicobacter pylori infection and nonsteroidal anti inflammatory drugs in peptic ulcer disease. Can J Gastroenterol, 2006, 20: 277-280.
8Metz DC, Sostek MB, Ruszniewski P, et al. Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. Am J Gastroenterol, 2007, 102:2648-2654.
9Egan BJ, Katicic M, O'Connor HJ, et al. Treatment of Helicobacter pylori. Helicobacter, 2007, 12:31-37.
10Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2000. 14: 715-718.
